Hamza Coban
@cobanmd
Followers
293
Following
879
Media
7
Statuses
249
Clinical Neuroimmunologist, Asst. Prof. of Neurology @UConnHealth. Former @pennmedicine @childrensphila @UConnNeurology @Hacettepetip
Farmington, CT
Joined July 2017
Friends, I would like to share our work at @ISSCR education committee in collaboration with @harvardmed, the first CME course for clinicians and students #stem #cells #medicine, this open access course is translated in 5 languages. please RT @Pluchinolab @pknoepfler @Nature
Our new open-access course jointly provided with @HarvardMed is live! Expert-led education on stem cell medicine for healthcare providers. Available in 6 languages & eligible for AMA PRA Category 1 CreditsTM. Learn more: https://t.co/TS7fOWEOIh
0
7
17
Yesterday, the House released a 389-page tax bill that includes trillions in tax cuts. I read every single page so you don’t have to. Here’s everything you need to know: 🧵
140
583
2K
MS awareness month to us, is every month, every day of the year!. Self-awareness about MS is an important goal to achieve for all of us, doctors, patients and families during the whole #2024 #holidayseason @uconnhealth @mssociety @AANmember
https://t.co/h8o0qTtTuy
1
1
2
Communication is key, but how do you overcome cultural and language hurdles that can lead to social detriments of heath? At #UConnHealth, we have the right people in the right setting. https://t.co/tlpWjgN7e1
today.uconn.edu
UConn Health’s bilingual medical assistants help address social determinants of health
0
1
1
Thanks @uconnhealth @cobanmd for highlighting one aspect of the great team that include Nurses and MAs in all Neuroscience units and beyond, everyday they help our patients with culturally appropriate care. They are tremendous advocate to those in need. @AANmember @mssociety
Communication is key, but how do you overcome cultural and language hurdles that can lead to social detriments of heath? At #UConnHealth, we have the right people in the right setting. https://t.co/tlpWjgN7e1
0
1
5
2024 TM Together | Community Q&A https://t.co/AJQfVU1IUA
@wearesrna @uconnhealth @DrJim4MS @mssociety
0
2
4
Join us for our webinar, “Applying to Neurology Residency As An IMG,” on Friday, Sept. 6 at 7:30 am ET! Pre-registration is required: https://t.co/F19SKuK69J We hope to see you there! #neurotwitter #medtwitter
1
14
25
Her gün bir başka sahte bilimcinin adını duyuyorum. Dün paylaşılan akıllara zarar mahkeme kararında adı geçen Aidin Salih kimmiş diye biraz araştırdım. Okumak isteyenler yoruma bakabilir ama özetle: Eski hekim, sonradan şarlatan, ilelebet potansiyel katil!
605
824
7K
On June 12, join our community Q&A featuring Dr. Hamza Coban (@cobanmd) of @UConnHealth and Dr. Paula Barreras of @CedarsSinai! Bring your questions and concerns, and learn more about #TM. Learn more about this event at https://t.co/jMCf71RNFJ.
0
4
9
#WorldMSDay #MyMSDiagnosis Top trending paper in the past 12 months: VISIBLY #MultipleSclerosis: An educational tool to tackle the effects of health literacy on diverse communities (from @ShivamBrain @DrJim4MS @UConn @uconnhealth). 🔽 https://t.co/gd4Qqnd4TY
1
7
6
Congrats to our @uconnhealth #MS center coordinator and navigator Karen Nelson for her well deserved recognition as a 2024 Nightingale Award recipient. She is an extraordinary, hard-working and effective MS @mscare certified nurse. @AANmember @MSassociation @mssociety @cobanmd
Congratulations to Karen Altomari-Nelson, a 2024 Nightingale Award Recipient! The Nightingale Awards are based on peer nominations and honor candidates who exhibit a unique excellence in their field. #NationalNursesWeek
1
2
9
Congratulations to Karen Altomari-Nelson, a 2024 Nightingale Award Recipient! The Nightingale Awards are based on peer nominations and honor candidates who exhibit a unique excellence in their field. #NationalNursesWeek
0
2
4
Many thanks to Dr. Newsome from @HopkinsMedicine @hopkinsneurons for his outstanding seminar about (SPS) stiff person syndrome in our @uconnhealth neuroimmunology seminar. @mssociety
0
2
13
Check out this very informative article with my comments. It's on secondary progressive multiple sclerosis to educate our patients and families. https://t.co/ob49MRiRGw
@uconnhealth @mssociety @DrJim4MS
healthcentral.com
This stage of multiple sclerosis follows the initial relapsing-remitting form of the disease in some people. Here’s what to expect, experts say.
0
1
8
“Next steps will be exploring CAR-T cell therapies, stem cell therapies & immune tolerance induction for #NMO...An important unmet need is treatment of symptoms [&] issues w/ current [DMTs] such as immune suppression, opportunistic infections..." @cobanmd
neurologylive.com
Newly approved treatments in neuromyelitis optica spectrum disorder have shown efficacy in recent years, yet unaddressed concerns voiced by clinicians and patients living with the disease remain.
0
1
1
NMOSD progress: approval of treatments🎯AQP4-IgG that have led to⬇️relapse rates &⬆️outcomes. Challenges remain: treatments for seronegative #NMOSD, expanded access to therapies & unmet needs, eg, symptom management, long-term consequences of treatment.
neurologylive.com
Newly approved treatments in neuromyelitis optica spectrum disorder have shown efficacy in recent years, yet unaddressed concerns voiced by clinicians and patients living with the disease remain.
0
4
7
With my comments Treating NMOSD: Where Do We Go After Complement Inhibition's Success? https://t.co/9FwzzcqfsF via @neurology_live
@uconnhealth @DrJim4MS @MarinaC_Dyb
neurologylive.com
Newly approved treatments in neuromyelitis optica spectrum disorder have shown efficacy in recent years, yet unaddressed concerns voiced by clinicians and patients living with the disease remain.
0
5
21
Working with #UConnHealth students and collaborators from other institutions, Dr. Jaime Imitola created a bilingual resource to help overcome barriers in identifying early signs of #MultipleSclerosis. 🎧 Learn more in the latest Pulse Podcast. Listen now: https://t.co/QiITSpbnn6
0
2
2